BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 5540284)

  • 21. Hormonal replacement therapy--cardiovascular disease.
    Silfverstolpe G; Crona N
    Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of oral contraceptives on carbohydrate metabolism.
    Spellacy WN
    J Reprod Med; 1970 Jul; 5(1):20-4. PubMed ID: 5521767
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on drug diabetes. Abnormal carbohydrate metabolism caused by oral contraceptive agents].
    Ishigami R; Shiotani S; Yoshida A; Kawata T; Natori H
    Naika Hokan; 1968 Jan; 15(1):11-5. PubMed ID: 5690963
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Side effects of contraceptive drugs].
    Schreiner WE
    Schweiz Med Wochenschr; 1970 May; 100(18):778-84. PubMed ID: 5494369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral contraceptives, carbohydrate metabolism and diabetes mellitus].
    Ekoé JM; Vuille C; Albert J
    Sem Hop; 1983 Dec; 59(45):3162-6. PubMed ID: 6320410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diabetes and oral contraceptives].
    Blohmé G
    Nord Med; 1971 Oct; 86(40):1168-9. PubMed ID: 5131959
    [No Abstract]   [Full Text] [Related]  

  • 28. [Calculation of estrogenic and gestagenic activity of oral hormonal contraceptive agents including a tabular review].
    Kless-Och M
    Schweiz Rundsch Med Prax; 1972 Nov; 61(46):1418-24. PubMed ID: 5084999
    [No Abstract]   [Full Text] [Related]  

  • 29. The pathology of birth control.
    Craig JM
    Arch Pathol; 1975 May; 99(5):233-6. PubMed ID: 1093536
    [No Abstract]   [Full Text] [Related]  

  • 30. Complications of the new contraceptive preparations.
    Clinch J
    Ir Med J; 1978 Oct; 71(15):513-4. PubMed ID: 711437
    [No Abstract]   [Full Text] [Related]  

  • 31. [Arterial hypertension during treatment with estro-progestative agents].
    Dumont M; Pellissier B; Laforet J; Dick D
    J Med Lyon; 1971 Mar; 52(204):381-3. PubMed ID: 5135329
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cutaneous complications of estro-progestative agents: statistical study. Apropos of 562 users].
    Dugois P; Amblard P; Manent J; Deshors G
    Ann Dermatol Syphiligr (Paris); 1971; 98(5):479-86. PubMed ID: 4259026
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of hormonal contraceptive agents in the development of urinary calculi].
    Klinger G; Hesse A; Schneider HJ
    Zentralbl Gynakol; 1974 Feb; 96(8):248-53. PubMed ID: 4838792
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oral contraception and carbohydrate metabolism--the physiopathological explanation].
    Hilal M
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1213-7. PubMed ID: 12267513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations].
    Osler M
    Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492
    [No Abstract]   [Full Text] [Related]  

  • 36. Amenorrhea following oral contraceptives.
    Halbert DR; Christian CD
    Obstet Gynecol; 1969 Aug; 34(2):161-7. PubMed ID: 5816310
    [No Abstract]   [Full Text] [Related]  

  • 37. Growth of leiomyomata with estrogen--progestogen therapy.
    John AH; Martin R
    J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of glucose tolerance in females during oral contraception].
    Domány Z
    Zentralbl Gynakol; 1972 Feb; 94(6):191-5. PubMed ID: 5023016
    [No Abstract]   [Full Text] [Related]  

  • 39. [Extragonadal endocrine repercussions of long-term estro-progestational treatment].
    Rozenbaum H; Netter A
    Actual Endocrinol (Paris); 1973; 13(0):73-8. PubMed ID: 4367475
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complications of therapy in gynecology (morphological studies of the effects of female sex hormones and like substances) (review) (author's transl)].
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1972; 56():252-83. PubMed ID: 4130829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.